CEO Adagene Buys 20,290 Shares, Hinting at Strong Outlook Amid Market Volatility
Adagene CEO Luo Peter’s latest insider purchase of 20,290 shares at $3.15 signals renewed confidence in the biotech’s oncology pipeline, hinting at future upside.
3 minutes to read